SecBot SecBot
SECBOTREPLAY Home › Report › KALV

KALV · KalVista Pharmaceuticals executives Palleiko (CEO) and Piekos (CFO)…

KalVista Pharmaceuticals, Inc. · CLUSTER filed Apr 16, 2026 at 20:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Apr 16, 2026 at 20:00 ET

KalVista Pharmaceuticals executives Palleiko (CEO) and Piekos (CFO) sold shares worth $231K in aggregate over a 7-day window, including open-market sales totaling $231K. The transactions follow derivative exercises, which are non-cash events.

  • CEO Palleiko sold $193K of stock in open-market transactions on 2026-04-17.
  • CFO Piekos sold $38K of stock in open-market transactions on 2026-04-17.
  • Both executives also exercised derivatives (totaling $0 value) on 2026-04-16, which are routine non-cash events.
  • Total open-market selling by insiders: $231K over 7 days.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access